Beta Bionics ($BBNX) Insider Trading & Smart Money Activity
Beta Bionics, Inc. ($BBNX) has 3 insider trades and 5 13F position changes on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($168.35K), net -$168.35K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$168.35K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 5
- Analyst ratings on file
- 0
BBNX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 1 / 4 |
| Q3 2026 | 0 | 1 · $147.89K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 2 · $20.46K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All BBNX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Mark HopmanChief Commercial Officer | Sell (Open-market sale) 10b5-1 | 775 sh | $13.45K | -1.38% | SEC | Read | ||||
| Insider | Hopman MarkChief Commercial Officer | Sell (Open-market sale) 10b5-1 | 370 sh | $7.02K | -7.6% | — | |||||
| Insider | Jones ChristyDirector | Sell (Open-market sale) 10b5-1 | 6.43K sh | $147.89K | -14.9% | — | |||||
| 13F | Rtw Investments | Reduced | -500K sh | $31.34M | +24.9% | +52.0% | Read | ||||
| 13F | Rtw Investments | Reduced | -500K sh | $29.06M | +24.9% | +52.0% | Read | ||||
| 13F | Point72 Asset Management, L.P. | Added | +1.54M sh | $42.93M | +24.9% | +52.0% | Read | ||||
| 13F | Farallon Capital Management | Reduced | -706K sh | $56.54M | +24.9% | +52.0% | Read | ||||
| 13F | Farallon Capital Management | Reduced | -706K sh | $52.42M | +24.9% | +52.0% | — |
1W / 1M / 6M = how BBNX moved from the trade or filing date.
Insider trading in BBNX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Mark Hopman | Chief Commercial Officer | 1 | -$13.45K | 55.33K | Oct 14, 2026 |
| Hopman Mark | Chief Commercial Officer | 1 | -$7.02K | Oct 1, 2026 | |
| Jones Christy | Director | 1 | -$147.89K | Sep 22, 2026 |
Institutions moving BBNX (13F)
Frequently asked questions
Are BBNX insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $168.35K, a net -$168.35K.
What is the latest insider trade in BBNX?
Mark Hopman, Chief Commercial Officer filed a sell (open-market sale) of 775 sh worth $13.45K on Oct 14, 2026.
Which institutions changed their BBNX positions?
Recent 13F filers moving the stock include Rtw Investments, Farallon Capital Management and Point72 Asset Management, L.P..
Other medical devices stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.